Browsing by Yonsei Author : Paik, Soon Myung

Name:
백순명 [Paik, Soon Myung] http://orcid.org/0000-0001-9688-6480
Department :
College of Medicine - Dept. of Life Science
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(34977365100)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleYonsei Author(s)Type
2019A therapeutic strategy for chemotherapy-resistant gastric cancer via destabilization of both β-catenin and ras 김상우, 노성훈, 백순명, 이재은, 정재호Article
2018Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth 김한상, 김형범, 백순명, 송재진, 육종인, 이민구, 차용훈, 최은창Article
2018Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells with Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT김현석, 백순명, 이주영, 정재호, 최윤영Article
2018Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer백순명Article
2018AIRVF: a filtering toolbox for precise variant calling in Ion Torrent sequencing김상우, 백순명, 이한나Article
2018Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)백순명Article
2018Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial백순명Article
2018Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation김대준, 김진아, 김혜련, 박성용, 백순명, 심효섭, 윤미란, 이진구, 이한나, 조병철, 표경호, 홍민희Article
2018Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information김상우, 김한상, 백순명, 이민구Article
2017Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research백순명Article
201721-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy백순명Article
2017The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40백순명Article
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박규현, 박준철, 배수진, 백순명, 범승훈, 손태일, 신성관, 이상길, 이용찬, 이은영, 이한나, 임준석, 정민규, 정재호, 정현철, 최윤영, 형우진Article
2017Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma김은영, 김진아, 김혜련, 백순명, 심효섭, 이진구, 조병철, 홍민희Article
2017Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype 김원규, 김태일, 김호근, 민병소, 박민희, 백순명, 이현정, 홍성필Article
2017Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer김건민, 김승일, 박세호, 박형석, 박형순, 백순명, 손주혁, 정현철Article
2016CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer 백순명Article
2016Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy 김혜련, 백순명, 조병철, 표경호Article
2016Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative 김은영, 김혜련, 백순명, 심효섭, 임선민, 임승택, 조병철Article
2016Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial 백순명Article
2016EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines 김민환, 김주항, 김혜련, 문용화, 백순명, 임선민, 조병철Article
2015Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma 김대준, 김주항, 김현기, 김혜련, 김효송, 문용화, 박준철, 백순명, 신성관, 이상길, 이용찬, 이창걸, 정현수, 조병철, 표경호, 허진Article
2015Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma 강찬우, 강한나, 김대준, 김주항, 김혜련, 김환, 문용화, 백순명, 윤미란, 임선민, 장강원, 조병철, 표경호Article
2015Prognostic Tests for Estrogen Receptor-Positive Breast Cancer: Need for Global Consideration and Further Evolution김승일, 김지예, 백순명Article
2015Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial백순명Article
2015A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2백순명Article
2015Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck고윤우, 권형주, 김주항, 김한상, 김혜련, 백순명, 이민구, 이지현, 정인경, 조병철, 최은창Article
2015Nanomaterials for theranostics: Recent advances and future challenges백순명, 허용민Article
2015Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial백순명Article
2015Prospective Validation of a 21-Gene Expression Assay in Breast Cancer 백순명Article
2015Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine 김현석, 백순명, 성여진Article
2014Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.백순명Article
2013Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31백순명Article
2013Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08백순명Article
1

Browse